Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients
- PMID: 971548
- DOI: 10.1111/j.1365-2265.1976.tb01971.x
Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients
Abstract
In ten normal subjects and in twenty acromegalic patients plasma levels of growth hormone were studied after administration of L-dopa and a dopamine infusion. In the ten normal subjects L-dopa, but not dopamine, increased plasma levels of GH. In the acromegalic patients both L-dopa and dopamine were followed by an inhibition of GH release. Since dopamine does not cross the blood-brain barrier, these results, although not excluding a site of action at median eminence level, support the thesis that the inhibitory effect of dopaminergic stimulation on GH release in acromegaly possibly involves receptors present on GH-secreting cells.
Similar articles
-
Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.J Clin Endocrinol Metab. 1987 Feb;64(2):255-60. doi: 10.1210/jcem-64-2-255. J Clin Endocrinol Metab. 1987. PMID: 3793848
-
Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.Eur J Clin Pharmacol. 1985;27(6):707-11. doi: 10.1007/BF00547054. Eur J Clin Pharmacol. 1985. PMID: 3921384
-
Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.Clin Endocrinol (Oxf). 1979 Dec;11(6):645-56. doi: 10.1111/j.1365-2265.1979.tb03120.x. Clin Endocrinol (Oxf). 1979. PMID: 119594
-
[Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1990 Jun;12(3):168-72. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1990. PMID: 2150352 Chinese.
-
Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.J Clin Endocrinol Metab. 1977 Mar;44(3):465-73. doi: 10.1210/jcem-44-3-465. J Clin Endocrinol Metab. 1977. PMID: 838847
Cited by
-
Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.Br J Clin Pharmacol. 1978 Oct;6(4):303-9. doi: 10.1111/j.1365-2125.1978.tb00856.x. Br J Clin Pharmacol. 1978. PMID: 359016 Free PMC article. Clinical Trial.
-
The Parkinson's disease death rate: carbidopa and vitamin B6.Clin Pharmacol. 2014 Oct 21;6:161-9. doi: 10.2147/CPAA.S70707. eCollection 2014. Clin Pharmacol. 2014. Retraction in: Clin Pharmacol. 2021 Mar 03;13:41. doi: 10.2147/CPAA.S308256. PMID: 25364278 Free PMC article. Retracted.
-
Neurotransmitter testing of the urine: a comprehensive analysis.Open Access J Urol. 2010 Oct 7;2:177-83. doi: 10.2147/OAJU.S13370. eCollection 2010. Open Access J Urol. 2010. Retraction in: Res Rep Urol. 2020 Dec 16;12:661. doi: 10.2147/RRU.S296319. PMID: 24198626 Free PMC article. Retracted.
-
Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.J Endocrinol Invest. 1979 Jul-Sep;2(3):307-31. doi: 10.1007/BF03350424. J Endocrinol Invest. 1979. PMID: 231066 Review. No abstract available.
-
Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality.J Clin Invest. 1980 Jan;65(1):146-53. doi: 10.1172/JCI109644. J Clin Invest. 1980. PMID: 7350194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources